Previous Chapter: B9. Antiprogestins and the Treatment of Breast Cancer
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 229
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 230
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 231
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 232
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 233
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 234
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 235
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 236
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 237
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 238
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 239
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 240
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 241
Suggested Citation: "B10. Uses of RU 486 as an Antiglucocoticoid." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
Page 242
Next Chapter: B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.